179 related articles for article (PubMed ID: 12230412)
1. Doxorubicin-dependent reduction of ferrylmyoglobin and inhibition of lipid peroxidation: implications for cardiotoxicity of anticancer anthracyclines.
Menna P; Salvatorelli E; Giampietro R; Liberi G; Teodori G; Calafiore AM; Minotti G
Chem Res Toxicol; 2002 Sep; 15(9):1179-89. PubMed ID: 12230412
[TBL] [Abstract][Full Text] [Related]
2. Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin.
Cartoni A; Menna P; Salvatorelli E; Braghiroli D; Giampietro R; Animati F; Urbani A; Del Boccio P; Minotti G
J Biol Chem; 2004 Feb; 279(7):5088-99. PubMed ID: 14634026
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity.
Minotti G; Mancuso C; Frustaci A; Mordente A; Santini SA; Calafiore AM; Liberi G; Gentiloni N
J Clin Invest; 1996 Aug; 98(3):650-61. PubMed ID: 8698856
[TBL] [Abstract][Full Text] [Related]
4. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
Menna P; Salvatorelli E; Minotti G
Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277
[TBL] [Abstract][Full Text] [Related]
5. Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.
Minotti G; Cavaliere AF; Mordente A; Rossi M; Schiavello R; Zamparelli R; Possati G
J Clin Invest; 1995 Apr; 95(4):1595-605. PubMed ID: 7706466
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of myoglobin-dependent lipid peroxidation by adriamycin.
Trost LC; Wallace KB
Biochem Biophys Res Commun; 1994 Oct; 204(1):23-9. PubMed ID: 7945364
[TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone: propensity for free radical formation and lipid peroxidation--implications for cardiotoxicity.
Novak RF; Kharasch ED
Invest New Drugs; 1985; 3(2):95-9. PubMed ID: 2991163
[TBL] [Abstract][Full Text] [Related]
8. Anthracycline metabolism and toxicity in human myocardium: comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite.
Minotti G; Licata S; Saponiero A; Menna P; Calafiore AM; Di Giammarco G; Liberi G; Animati F; Cipollone A; Manzini S; Maggi CA
Chem Res Toxicol; 2000 Dec; 13(12):1336-41. PubMed ID: 11123976
[TBL] [Abstract][Full Text] [Related]
9. Peroxidation of linoleate at physiological pH: hemichrome formation by substrate binding protects against metmyoglobin activation by hydrogen peroxide.
Baron CP; Skibsted LH; Andersen HJ
Free Radic Biol Med; 2000 Feb; 28(4):549-58. PubMed ID: 10719236
[TBL] [Abstract][Full Text] [Related]
10. Effects by doxorubicin on the myocardium are mediated by oxygen free radicals.
Xu MF; Tang PL; Qian ZM; Ashraf M
Life Sci; 2001 Jan; 68(8):889-901. PubMed ID: 11213359
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the metmyoglobin-induced peroxidation of linoleic acid by dietary antioxidants: Action in the aqueous vs. lipid phase.
Vulcain E; Goupy P; Caris-Veyrat C; Dangles O
Free Radic Res; 2005 May; 39(5):547-63. PubMed ID: 16036331
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of metmyoglobin/H2O2-dependent low density lipoprotein lipid peroxidation by naturally occurring phenolic acids.
Laranjinha J; Vierira O; Almeida L; Madeira V
Biochem Pharmacol; 1996 Feb; 51(4):395-402. PubMed ID: 8619883
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoids.
Hüsken BC; de Jong J; Beekman B; Onderwater RC; van der Vijgh WJ; Bast A
Cancer Chemother Pharmacol; 1995; 37(1-2):55-62. PubMed ID: 7497597
[TBL] [Abstract][Full Text] [Related]
14. The influence of doxorubicin and 4'-epi-doxorubicin on lipid peroxidation in mouse heart, lungs and liver. Part II.
Pierściński G; Drzewoski J; Nowak D
Pol J Pharmacol; 1994; 46(1-2):55-9. PubMed ID: 7981772
[TBL] [Abstract][Full Text] [Related]
15. Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats.
Haybar H; Goudarzi M; Mehrzadi S; Aminzadeh A; Khodayar MJ; Kalantar M; Fatemi I
Biomed Pharmacother; 2019 Jan; 109():530-535. PubMed ID: 30551518
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.
Mimnaugh EG; Gram TE; Trush MA
J Pharmacol Exp Ther; 1983 Sep; 226(3):806-16. PubMed ID: 6411900
[TBL] [Abstract][Full Text] [Related]
17. [Effects of anthracycline drugs (aclarubicin, daunorubicin, doxorubicin, epirubicin, pirarubicin) on mouse acute toxicity and rat liver microsomal lipid peroxidation].
Shinozawa S; Gomita Y; Araki Y
Gan To Kagaku Ryoho; 1992 Jun; 19(6):805-9. PubMed ID: 1605657
[TBL] [Abstract][Full Text] [Related]
18. Ambroxol inhibits doxorubicin-induced lipid peroxidation in heart of mice.
Nowak D; Pierscinski G; Drzewoski J
Free Radic Biol Med; 1995 Nov; 19(5):659-63. PubMed ID: 8529925
[TBL] [Abstract][Full Text] [Related]
19. In vitro nonenzymatic glycation enhances the role of myoglobin as a source of oxidative stress.
Roy A; Sen S; Chakraborti AS
Free Radic Res; 2004 Feb; 38(2):139-46. PubMed ID: 15104207
[TBL] [Abstract][Full Text] [Related]
20. A Chemosensitizer Drug: Disulfiram Prevents Doxorubicin-Induced Cardiac Dysfunction and Oxidative Stress in Rats.
Sonawane VK; Mahajan UB; Shinde SD; Chatterjee S; Chaudhari SS; Bhangale HA; Ojha S; Goyal SN; Kundu CN; Patil CR
Cardiovasc Toxicol; 2018 Oct; 18(5):459-470. PubMed ID: 29779119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
